These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 7903148

  • 1. Adverse reactions with beta-adrenoceptor blocking drugs. An update.
    Lewis RV, Lofthouse C.
    Drug Saf; 1993 Oct; 9(4):272-9. PubMed ID: 7903148
    [Abstract] [Full Text] [Related]

  • 2. Adverse reactions and interactions with beta-adrenoceptor blocking drugs.
    Lewis RV, McDevitt DG.
    Med Toxicol; 1986 Oct; 1(5):343-61. PubMed ID: 2878346
    [Abstract] [Full Text] [Related]

  • 3. Antihypertensive drugs and airway function, with special reference to calcium channel blockade.
    Löfdahl CG.
    J Cardiovasc Pharmacol; 1989 Oct; 14 Suppl 10():S40-51; discussion S59-62. PubMed ID: 2483571
    [Abstract] [Full Text] [Related]

  • 4. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
    Baker JG.
    Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Beta-adrenoceptor blocking drugs: adverse reactions and drug interactions.
    Kendall MJ, Beeley L.
    Pharmacol Ther; 1983 Feb; 21(3):351-69. PubMed ID: 6138787
    [Abstract] [Full Text] [Related]

  • 7. Beta-blocking agents with vasodilator activity.
    Rosendorff C.
    J Hypertens Suppl; 1993 Jun; 11(4):S37-40. PubMed ID: 8104240
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative properties of various beta-blockers, with an outlook to the future.
    van Zwieten PA.
    Clin Physiol Biochem; 1990 Jun; 8 Suppl 2():18-27. PubMed ID: 1982758
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Do we need a new classification of beta-blockers?
    Kendall MJ.
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():27-9. PubMed ID: 1973460
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of beta-blockade and ACE inhibitors in the treatment of hypertension.
    Prichard BN, Saul PA.
    J Cardiovasc Pharmacol; 1990 Jun; 16 Suppl 5():S81-5. PubMed ID: 11527141
    [Abstract] [Full Text] [Related]

  • 17. [Beta blockers--1997 update].
    Stoschitzky K, Klein W.
    Wien Klin Wochenschr; 1997 Apr 11; 109(7):222-31. PubMed ID: 9206901
    [Abstract] [Full Text] [Related]

  • 18. [Beta blockers and bronchial asthma].
    Im Hof VI.
    Praxis (Bern 1994); 1995 Mar 14; 84(11):319-20. PubMed ID: 7724948
    [Abstract] [Full Text] [Related]

  • 19. [True and presumed contraindications of beta blockers. Peripheral vascular disease, diabetes mellitus, chronic bronchopneumopathy].
    Pozzi R.
    Ital Heart J Suppl; 2000 Aug 14; 1(8):1031-7. PubMed ID: 10993010
    [Abstract] [Full Text] [Related]

  • 20. The importance of circadian rhythms on drug response in hypertension and coronary heart disease--from mice and man.
    Lemmer B.
    Pharmacol Ther; 2006 Sep 14; 111(3):629-51. PubMed ID: 16480770
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.